期刊
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
卷 128, 期 6, 页码 1185-U500出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2011.09.011
关键词
Medication adherence; inhaled corticosteroids; asthma; patient compliance; asthma exacerbations
资金
- Fund for Henry Ford Hospital
- American Asthma Foundation
- National Institute of Allergy and Infectious Diseases [R01AI079139, R01AI061774]
- National Heart, Lung, and Blood Institute (NHLBI) [R01HL079055]
- National Institute of Diabetes and Digestive and Kidney Diseases [R01DK064695]
- National Institutes of Health (NIH)
- NHLBI/NIH [R01HL078885, R01HL088133, K23HL093023-01]
- Flight Attendant Medical Research Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health)
Background: Asthma is an inflammatory condition often punctuated by episodic symptomatic worsening, and accordingly, patients with asthma might have waxing and waning adherence to controller therapy. Objective: We sought to measure changes in inhaled corticosteroid (ICS) adherence over time and to estimate the effect of this changing pattern of use on asthma exacerbations. Methods: ICS adherence was estimated from electronic prescription and fill information for 298 participants in the Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity. For each patient, we calculated a moving average of ICS adherence for each day of follow-up. Asthma exacerbations were defined as the need for oral corticosteroids, an asthma-related emergency department visit, or an asthma-related hospitalization. Proportional hazard models were used to assess the relationship between ICS medication adherence and asthma exacerbations. Results: Adherence to ICS medications began to increase before the first asthma exacerbation and continued afterward. Adherence was associated with a reduction in exacerbations but was only statistically significant among patients whose adherence was greater than 75% of the prescribed dose (hazard ratio, 0.61; 95% CI, 0.41-0.90) when compared with patients whose adherence was 25% or less. This pattern was largely confined to patients whose asthma was not well controlled initially. An estimated 24% of asthma exacerbations were attributable to ICS medication nonadherence. Conclusions: ICS adherence varies in the time period leading up to and after an asthma exacerbation, and nonadherence likely contributes to a large number of these exacerbations. High levels of adherence are likely required to prevent these events. (J Allergy Clin Immunol 2011;128:1185-91.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据